Comparative endometrial histology in postmenopausal women with sequential hormone replacement therapy of estradiol and, either chlormadinone acetate or micronized progesterone

Maturitas

Volumn 41, Issue 2, 2002, Pages 115-121

  Jondet, M ^a   Maroni, M ^b   Yaneva, H ^b   Brin, S ^b   Peltier Pujol, F ^b   Pelissier C ^c  

^a Cabinet d'Anatomie Et De Cytologie Pathologiques   (France)

^b SANOFI   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Chlormadinone acetate; Endometrial biopsy; Estradiol; Hormone replacement therapy; Micronized progesterone; Postmenopausal women

Indexed keywords

CHLORMADINONE ACETATE; ESTRADIOL; PROGESTERONE;

ADULT; ARTICLE; BIOPSY; CELL PROLIFERATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOMETRIUM; ENDOMETRIUM ATROPHY; EPITHELIUM CELL; FEMALE; HISTOLOGY; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; NORMAL HUMAN; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; CHLORMADINONE ACETATE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ENDOMETRIUM; ESTRADIOL; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PROGESTERONE;

EID: 0037176782     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(01)00260-2     Document Type: Article

References (24)

1. Hormonal pathology of the endometrium
2. Chlormadinone acetate versus micronized progesterone in the sequential combined hormone replacement therapy of the menopause
3. Endometrial morphology in asymptomatic postmenopausal women
4. Endometrial safety of continuous combined hormone replacement therapy with 17 beta-estradiol (1 or 2 mg) and dydrogesterone
5. Dating the endometrial biopsy
6. Evaluation of nine different fixatives - 2 - Preservation of IgG, IgA and secretory component in a artificial immunohistochemical test substrate
7. Functional disturbances of the endometrium
8. Histologic classification and pathologic findings for endometrial biopsy specimens obtained from 2964 perimenopausal and postmenopausal women undergoing screening for continuous hormones as replacement therapy (CHART 2 Study)
9. Comparison of endometrial growth produced by unopposed conjugated estrogens or by micronized estradiol in postmenopausal women
10. Relationship between serum estradiol levels and the increases of high-density lipoprotein levels in postmenopausal women treated with oral estradiol
11. Substitution hormonale destinée aux receveuses du don d'ovocytes: Un modèle pour analyser l'action de la progestérone sur l'endomètre
12. Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure
13. Long term effect of percutaneous estradiol on bone loss and bone metabolism in postmenopausal hysterectomized women
14. Receptor binding as a tool in the development of new bioactive steroids
15. Antiproliferative effects of low-dose micronized progesterone
16. Progestatifs
17. Endometrial status in post-menopausal women on long-term continuous combined hormone replacement therapy (Kliofem). A comparative study of endometrial biopsy, out patient hysteroscopy and transvaginal ultrasound
18. Clinical and endometrial effects of oestradiol and progesterone in post-menopausal women
19. The effect of high-dose medium- and long-term progestogen exposure on endometrial vessels
20. Aspects hystéroscopiques et histologiques de l'endomètre sous traitements progestatifs
21. Microvascular density in conditions of endometrial atrophy